TY - JOUR T1 - Outpatient smoking cessation in non-healthy smokers JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - 3340 AU - Barbara Sonneville AU - Bihiyga Salhi AU - Gina Van Damme AU - Eric Derom AU - Jan van Meerbeeck Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/3340.abstract N2 - BackgroundIn ‘healthy’ smokers, intensive counseling with nicotine replacement therapy (NRT) results in a sustained 1 year quit rate (QR) of 22% (Van Weel C. et al, 2004). The value of this approach in smokers with comorbidities is unclear.MethodsWe retrospectively analyzed all 263 consecutive patients (pts) referred to the smoking clinic between Jan 2010 and Dec 2012. Smoking cessation (SC) intervention consisted of NRT and 6 clinic visits after quit date with carbon monoxid validated SC. Point prevalent QR is defined as the number of sustained quitters at 1 year over all participants receiving a quit date. Drop-outs are censored as failures. Data are reported as medians. Charlson Comorbidity Index (CCI) was categorized (Charlson M.E. et al, 1987). A multivariate analysis of prognostic factors was conducted with backward logistic regression.Results117 pts were included: 57% men, 50 years (21-78), pack year 30 (2-80). 58% of patients had a mild, 35% a moderate and 7% a severe CCI. Fagerström Index was 5 (0-10) with 23% high and 26% very high dependence. Comorbidities were COPD (35%), alcohol abuse (30%), depression (26%), cancer (13%), diabetes (13%), asthma (13%), peripheral arterial disease (PAD) (9%) and ischemic heart disease (4%). Pts attended 4 clinic visits (2-10) with 71% NRT compliance. Overall QR was 18% (95%CI 12.1-27). Comorbid cancer (OR 10.2, 95%CI 2.7-39.2, p=0.001) and PAD (OR 5.2, 95%CI 1.1-24.1, p=0.034) were independent prognostic factors for successful SC.ConclusionIn this series of non-healthy smokers, QR after intensive counseling and NRT is similar as reported in healthy ones. Comorbid cancer and PAD are prognostic for successful SC. An updated analysis will be presented at the meeting. ER -